Brief: New England Journal Of Medicine Publishes Positive Long-Term Data On Freeline’S Gene Therapy Candidate Flt180a For People With Hemophilia B

Freeline Therapeutics Holdings

21/07/2022 12:34

July 21 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES POSITIVE
LONG-TERM
DATA ON FREELINE’S GENE THERAPY CANDIDATE FLT180A FOR PEOPLE
WITH HEMOPHILIA B

Source text for Eikon:  ID:nGNX2zbT4l 
Further company coverage:  FRLN.O 

 ((Reuters.Briefs@thomsonreuters.com;))